Medical device recalls High risk

Empowered Diagnostics LLC recalls ImmunoPass , COVID-19 Neutralizing Antibody Test, NAB 900-60

Recall date
December 22, 2021
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0481-2022
FDA classification
Class I
Brand / firm
Empowered Diagnostics LLC
Sold / distributed
US Nationwide Distribution

Why it was recalled

COVID test kits were offered for sale and distributed to consumers in the United States without marketing approval, clearance, or authorization from FDA.

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

ImmunoPass , COVID-19 Neutralizing Antibody Test, NAB 900-60

Get recall alerts

Free email alert whenever Empowered Diagnostics LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Empowered Diagnostics LLC